Recent reports also showed a promising use of GRPR ligands for imaging of gastrointestinal stromal tumors [7, 8], rendering radiolabeled GRPR-targeted compounds promising for theranostic applications in different cancers. The gene discussed is GRPR; the disease is cancer.